Skip to main content

Krasney Karen's Form 4 filing

Capricor Therapeutics, Inc. (CAPR) · filed Jun 24, 2026

Accession no.
0001593086-26-000010
Filed
Jun 24, 2026
Trade date
Jun 22-24, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $27.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Krasney KarenCIK 0001593086Officer (EVP, GENERAL COUNSEL)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 22, 2026Common StockMOption exerciseAcquired+500$3.18+$1,59031,047Direct
Jun 22, 2026Common StockSSaleDisposed−500$30.00−$15,00030,547Direct
Jun 24, 2026Common StockMOption exerciseAcquired+400$3.18+$1,27230,947Direct
Jun 24, 2026Common StockSSaleDisposed−400$30.00−$12,00030,547Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 22, 2026Common StockMOption exerciseDisposed−500$0.00$055,761Direct
Jun 24, 2026Common StockMOption exerciseDisposed−400$0.00$055,361Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)